FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹327 Cr | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr |
What is the latest Total Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹327 Cr |
| Mar2024 | ₹167 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹74 Cr |
| Mar2021 | ₹86 Cr |
How is Total Current Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹327 Cr | 96.20 | |
| Mar2024 | ₹167 Cr | 19.46 | |
| Mar2023 | ₹140 Cr | 89.36 | |
| Mar2022 | ₹74 Cr | -14.70 | |
| Mar2021 | ₹86 Cr | - | |
Compare Total Current Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,162.1 Cr | 2.2% | 28% | 212.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 2.2% |
28% |
212.6% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses